IMS Health (IMS) Earns Daily Media Impact Rating of 0.21

Media headlines about IMS Health (NYSE:IMS) have been trending somewhat positive on Sunday, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. IMS Health earned a coverage optimism score of 0.21 on Accern’s scale. Accern also assigned media coverage about the information technology services provider an impact score of 42.9092675562243 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

IMS Health has a 52-week low of $22.36 and a 52-week high of $31.59. The company has a market cap of $10,330.00 and a P/E ratio of 74.62. The company has a debt-to-equity ratio of 2.53, a current ratio of 1.12 and a quick ratio of 1.12.

COPYRIGHT VIOLATION NOTICE: “IMS Health (IMS) Earns Daily Media Impact Rating of 0.21” was originally posted by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.com-unik.info/2018/01/07/ims-health-ims-earns-daily-media-impact-rating-of-0-21.html.

IMS Health Company Profile

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Insider Buying and Selling by Quarter for IMS Health (NYSE:IMS)

Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit